Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | XBP1 | P17861 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CES2 | O00748 | 2/20 | 0.37 |
| ▸ | CES1 | P23141 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | DAO | P14920 | 1/20 | 0.37 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 3/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.36 |
| ▸ | GLA | P06280 | 2/20 | 0.36 |
| ▸ | GAA | P10253 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134312 | 0.86 | ALDH1A1 (0.52) | ALDH1A1KMT2AMEN1MAPTCYP19A1 | |
| SCHEMBL10593807 | 0.83 | ALDH1A1 (0.46) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| Cyanamide SCHEMBL7212151 | 0.80 | ALDH1A1 (0.52) | ALDH1A1KMT2AMEN1MAPTCYP19A1 | |
| Guanidine SCHEMBL3878079 | 0.77 | PRSS1 (0.50) | ALDH1A1KMT2AMEN1MAPTCYP19A1 | |
| SCHEMBL8999045 | 0.75 | CES2 (0.50) | ALDH1A1KMT2AMEN1MAPTCYP19A1 | |
| SCHEMBL9068811 | 0.74 | SMN1; SMN2 (0.43) | ALDH1A1KMT2AMEN1MAPTCYP19A1 | |
| SCHEMBL1712503 | 0.73 | KMT2A (0.46) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL3094764 | 0.72 | EGFR (0.52) | ALDH1A1KMT2AMEN1MAPTLMNA | |
| SCHEMBL28310325 | 0.72 | CYP19A1 (0.42) | ALDH1A1KMT2AMEN1MAPTCYP19A1 | |
| SCHEMBL9068806 | 0.71 | CES2 (0.50) | ALDH1A1KMT2AMEN1MAPTLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11332564-B2 | Method to produce stimuli sensitive UV absorbing polymers | GALAXY SURFACTANTS LTD. (IN) | 2022-05-17 | — | — | US | claimed |
| US-20210301052-A1 | METHOD TO PRODUCE STIMULI SENSITIVE UV ABSORBING POLYMERS | GALAXY SURFACTANTS LTD (IN) | 2021-09-30 | — | — | US | claimed |
| EP-2598471-B1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEM CO (US) | 2020-11-25 | — | — | EP | claimed |
| EP-3725756-A2 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING AMINES, OR COLORANTS, AND AN ADDUCT OF THE THREE COMPOUNDS N-(N-BUTYL) THIOPHOSPHORIC ACID TRIAMIDE (NBPT), UREA, AND FORMALDEHYDE | BASF SE (DE) | 2020-10-21 | — | — | EP | claimed |
| CN-105899612-B | Increase-volume composition, the product formed by it and the method for manufacturing them | 沙特基础工业全球技术有限公司 | 2018-05-29 | — | — | CN | claimed |
| US-20170369385-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2017-12-28 | — | — | US | claimed |
| EP-3237360-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO) PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2017-11-01 | — | — | EP | claimed |
| WO-2016103168-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO) PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | BASF SE (DE) | 2016-06-30 | — | — | WO | claimed |
| US-8846723-B2 | Esters of O-substituted hydroxy carboxylic acids and preparations thereof | EASTMAN CHEMICAL COMPANY (US) | 2014-09-30 | — | — | US | claimed |
| EP-2509579-B1 | NOVEL COMPOUND | DSM IP ASSETS BV (NL) | 2014-09-03 | — | — | EP | claimed |
| EP-2598471-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | Eastman Chemical Company (US) | 2013-06-05 | — | — | EP | claimed |
| US-20120288456-A1 | NOVEL COMPOUND | DSM IP ASSETS B.V. (NL) | 2012-11-15 | — | — | US | claimed |
| EP-2509579-A2 | NOVEL COMPOUND | DSM IP Assets B.V. (NL) | 2012-10-17 | — | — | EP | claimed |
| WO-2012015790-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2012-02-02 | — | — | WO | claimed |
| US-20120029198-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | EASTMAN CHEMICAL COMPANY (US) | 2012-02-02 | — | — | US | claimed |
| WO-2011070077-A2 | NOVEL COMPOUND | DSM IP ASSETS B.V. (NL) | 2011-06-16 | — | — | WO | claimed |
| US-12037300-B2 | Use of a cation source to prevent decomposition of (thio)phosphoric acid triamide urease inhibitors when a phosphorus-containing fertilizer is present | BASF SE (DE) | 2024-07-16 | — | — | US | disclosed |
| EP-3436416-B1 | USE OF A CATION SOURCE TO PREVENT DECOMPOSITION OF (THIO)PHOSPHORIC ACID TRIAMIDE UREASE INHIBITORS WHEN A PHOSPHORUS-CONTAINING FERTILIZER IS PRESENT | BASF SE (DE) | 2024-01-24 | — | — | EP | disclosed |
| EP-0113318-B1 | (4-HYDROXYPHENYLTHIO)-IMIDE STABILIZERS | CIBA-GEIGY AG (CH) | 1987-09-16 | — | — | EP | disclosed |
| EP-0053098-A2 | Alkanol-amine esters of cyclic 1,1'-biphenyl-2,2'-diyl and alkylidene-1,1'-biphenyl-2,2'-diyl phosphites | CIBA-GEIGY AG (CH) | 1982-06-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029198-A1 | ESTERS OF O-SUBSTITUTED HYDROXY CARBOXYLIC ACIDS AND PREPARATIONS THEREOF | HCAR2, OXER1, FASN | ALDH1A1 254/4885KMT2A 2442/4885MEN1 3919/4885 |
| US-11332564-B2 | Method to produce stimuli sensitive UV absorbing polymers | CUTA, C9, ERCC1 | ALDH1A1 1117/4885KMT2A 4827/4885MEN1 606/4885 |
| US-20170369385-A1 | COMPOSITIONS WITH IMPROVED UREASE-INHIBITING EFFECT COMPRISING (THIO)PHOSPHORIC ACID TRIAMIDE AND FURTHER COMPOUNDS SUCH AS AMINES AND COLORANTS | SLC14A1, XDH, PNP | ALDH1A1 1062/4885KMT2A 2627/4885MEN1 4263/4885 |
| US-20210301052-A1 | METHOD TO PRODUCE STIMULI SENSITIVE UV ABSORBING POLYMERS | CUTA, C9, ERCC1 | ALDH1A1 1117/4885KMT2A 4827/4885MEN1 606/4885 |
| US-20120288456-A1 | NOVEL COMPOUND | MGLL, DGKZ, DGAT2 | ALDH1A1 2800/4885KMT2A 1768/4885MEN1 4020/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.